ALUMBRIA XR-ODT Trademark

Trademark Overview

On Thursday, June 13, 2019, a trademark application was filed for ALUMBRIA XR-ODT with the United States Patent and Trademark Office. The USPTO has given the ALUMBRIA XR-ODT trademark a serial number of 88471408. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Neos Therapeutics, Inc.. The ALUMBRIA XR-ODT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disease and disorders of the central nervous system
alumbria xr-odt

General Information

Serial Number88471408
Word MarkALUMBRIA XR-ODT
Filing DateThursday, June 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of disease and disorders of the central nervous system
Disclaimer with Predetermined Text"XR-ODT"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeos Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050
Party NameNeos Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Prairie, TX 75050

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 25, 2021SOU EXTENSION 3 GRANTED
Saturday, September 25, 2021SOU EXTENSION 3 FILED
Saturday, September 25, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 1, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 29, 2021SOU EXTENSION 2 GRANTED
Monday, March 29, 2021SOU EXTENSION 2 FILED
Monday, March 29, 2021SOU TEAS EXTENSION RECEIVED
Saturday, October 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 8, 2020SOU EXTENSION 1 GRANTED
Thursday, October 8, 2020SOU EXTENSION 1 FILED
Thursday, October 8, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 14, 2020ASSIGNED TO LIE
Monday, January 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 10, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 10, 2019NON-FINAL ACTION E-MAILED
Tuesday, September 10, 2019NON-FINAL ACTION WRITTEN
Thursday, September 5, 2019ASSIGNED TO EXAMINER
Tuesday, June 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 17, 2019NEW APPLICATION ENTERED

Related Keywords

alumbria central nervous system disorders disease preparations treatment pharmaceutical